Missing/wrong data?
Log in to edit
MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
scientific article published on 27 August 2013
Author/s
author: Michael Boe Møller, Alexandar Tzankov, Santiago Montes-Moreno, Karen Dybkaer, Govind Bhagat, Han van Krieken, Jane Winter, Ronald S Go, Carlo Visco, L Jeffrey Medeiros
Work details
Publication date
August 27, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.